Health ❯Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Clinical Trials Drug Safety Weight Loss Weight Loss Drugs Drug Regulation Cancer Treatment Medications

BMJ Review Finds Tramadol Provides Minimal Chronic Pain Relief, Doubles Serious Harm Risk

UK guidance now urges curbing tramadol for chronic pain due to likely harms outweighing limited benefit.

Amazon to Install Prescription Kiosks at One Medical Clinics in Los Angeles Starting December

Novo Nordisk Expands $499 Wegovy and Ozempic Pricing to Costco and Sam’s Club

India Investigates Child Cough-Syrup Deaths as Rajasthan Targets Suspect Drugs

FDA Approves Libtayo as First Adjuvant Therapy for High-Risk CSCC

GLP-1 Weight-Loss Drugs Linked to Atypical PET-CT Signals That Can Confound Cancer Reads

Zenas BioPharma Licenses InnoCare’s Orelabrutinib for Autoimmune Use in Deal Topping $2 Billion

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Discovery

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

AstraZeneca’s Baxdrostat Hits Phase 3 Goal With 24‑Hour Blood‑Pressure Cuts

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

FDA Signals Possible Revisions to Menopause Hormone Therapy Black Box Warning

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Amgen Launches AmgenNow to Sell Repatha Direct to U.S. Patients at $239 a Month

Abivax’s Obefazimod Meets Phase 3 Week-8 Remission Goals in Ulcerative Colitis

Vltava Fund Adds Novo Nordisk, Marex and Fiserv in Q3 Portfolio Update

FDA Approves Zoryve 0.05% Cream for Children Ages 2–5 With Mild to Moderate Atopic Dermatitis